BIO-key International Inc. (NASDAQ:BKYI – Get Free Report)’s share price passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $4.44 and traded as high as $4.60. BIO-key International shares last traded at $3.76, with a volume of 72,730 shares trading hands.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of BIO-key International in a research note on Friday, July 17th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, BIO-key International currently has a consensus rating of “Sell”.
View Our Latest Report on BKYI
BIO-key International Trading Up 0.2%
Institutional Trading of BIO-key International
A hedge fund recently raised its position in BIO-key International stock. Geode Capital Management LLC grew its position in BIO-key International Inc. (NASDAQ:BKYI – Free Report) by 49.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 48,892 shares of the technology company’s stock after acquiring an additional 16,271 shares during the period. Geode Capital Management LLC owned about 0.45% of BIO-key International worth $26,000 at the end of the most recent quarter. 26.51% of the stock is owned by institutional investors.
BIO-key International Company Profile
BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.
In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.
Further Reading
- Five stocks we like better than BIO-key International
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
